Robert W. Ross - Net Worth and Insider Trading

Robert W. Ross Net Worth

The estimated net worth of Robert W. Ross is at least $89,017 dollars as of 2024-11-05. Robert W. Ross is the CEO of Surface Oncology Inc and owns about 83,193 shares of Surface Oncology Inc (SURF) stock worth over $89,017. Details can be seen in Robert W. Ross's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert W. Ross has not made any transactions after 2023-08-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert W. Ross

To

Robert W. Ross Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert W. Ross owns 2 companies in total, including Surface Oncology Inc (SURF) , and Xilio Therapeutics Inc (XLO) .

Click here to see the complete history of Robert W. Ross’s form 4 insider trades.

Insider Ownership Summary of Robert W. Ross

Ticker Comapny Transaction Date Type of Owner
SURF Surface Oncology Inc 2023-08-01 Chief Medical Officer
XLO Xilio Therapeutics Inc 2022-06-15 director

Robert W. Ross Latest Holdings Summary

Robert W. Ross currently owns a total of 1 stock. Robert W. Ross owns 83,193 shares of Surface Oncology Inc (SURF) as of August 1, 2023, with a value of $89,017.

Latest Holdings of Robert W. Ross

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SURF Surface Oncology Inc 2023-08-01 83,193 1.07 89,017

Holding Weightings of Robert W. Ross


Robert W. Ross Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert W. Ross has made a total of 9 transactions in Surface Oncology Inc (SURF) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Surface Oncology Inc is the sale of 16,713 shares on August 1, 2023, which brought Robert W. Ross around $15,710.

Insider Trading History of Robert W. Ross

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert W. Ross Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert W. Ross Ownership Network

Ownership Network List of Robert W. Ross

No Data

Ownership Network Relation of Robert W. Ross

Insider Network Chart

Robert W. Ross Owned Company Details

What does Surface Oncology Inc do?

Who are the key executives at Surface Oncology Inc?

Robert W. Ross is the Chief Medical Officer of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .

Surface Oncology Inc (SURF) Insider Trades Summary

Over the past 18 months, Robert W. Ross made 1 insider transaction in Surface Oncology Inc (SURF) with a net sale of 16,713. Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 9,434 shares made by Jessica Fees , a net sale of 7,042 shares made by Alison Oneill , and a net sale of 3,901 shares made by Chandra Adams .

In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.

Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Surface Oncology Inc Insider Transactions

No Available Data

Robert W. Ross Mailing Address

Above is the net worth, insider trading, and ownership report for Robert W. Ross. You might contact Robert W. Ross via mailing address: C/o Surface Oncology, 50 Hampshire St., 8th Floor, Cambridge Ma 02139.